|4Feb 25, 4:46 PM ET

Krop Julie 4

4 · AMAG PHARMACEUTICALS, INC. · Filed Feb 25, 2020

Insider Transaction Report

Form 4
Period: 2020-02-23
Krop Julie
SVP Clinical & Regulatory, CMO
Transactions
  • Tax Payment

    Common Stock

    2020-02-23$9.50/sh867$8,23783,032 total
  • Tax Payment

    Common Stock

    2020-02-25$8.84/sh1,155$10,21081,877 total
Footnotes (3)
  • [F1]Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,501 restricted stock units on February 23, 2020.
  • [F2]Reporting person's total beneficial ownership reflects the purchase of 2,500 shares through an Employee Stock Purchase Plan on November 30, 2019.
  • [F3]Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 3,333 restricted stock units on February 25, 2020.

Documents

1 file
  • 4
    wf-form4_158266714405265.xmlPrimary

    FORM 4